Sage Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	63,408	58,704	84,501	93,866	75,774	19,476	Upgrade
Market Cap Growth	-30.53%	-30.53%	-9.98%	23.88%	289.07%	118.50%	Upgrade
Enterprise Value	121,513	114,019	134,984	146,468	123,290	45,238	Upgrade
Last Close Price	29.86	27.62	39.72	44.11	35.55	9.18	Upgrade
PS Ratio	0.60	0.55	0.75	1.04	1.18	0.35	Upgrade
PB Ratio	-3.79	-3.50	-5.88	-10.66	-12.47	-2.93	Upgrade
P/FCF Ratio	8.35	7.73	11.45	17.84	-	-	Upgrade
P/OCF Ratio	6.67	6.18	9.25	10.13	-	-	Upgrade
EV/Sales Ratio	1.15	1.08	1.19	1.62	1.92	0.80	Upgrade
EV/EBITDA Ratio	18.97	17.80	19.37	23.54	28.58	8.16	Upgrade
EV/EBIT Ratio	33.63	31.56	30.52	36.74	55.01	12.62	Upgrade
EV/FCF Ratio	16.01	15.02	18.29	27.84	-	-	Upgrade
Debt / Equity Ratio	-3.52	-3.52	-4.03	-6.32	-8.62	-6.70	Upgrade
Debt / EBITDA Ratio	9.19	9.19	8.18	8.76	12.13	7.85	Upgrade
Debt / FCF Ratio	7.76	7.76	7.85	10.59	-	-	Upgrade
Asset Turnover	1.11	1.11	1.27	1.23	0.92	0.83	Upgrade
Inventory Turnover	2.24	2.24	2.80	3.32	2.31	2.16	Upgrade
Quick Ratio	0.08	0.08	0.09	0.08	0.07	0.06	Upgrade
Current Ratio	0.59	0.59	0.68	0.59	0.57	0.61	Upgrade
Return on Assets (ROA)	2.38%	2.38%	3.11%	3.39%	2.00%	3.30%	Upgrade
Return on Capital (ROIC)	5.27%	5.27%	6.11%	5.35%	3.33%	7.46%	Upgrade
Return on Capital Employed (ROCE)	20.50%	20.50%	20.30%	16.60%	9.50%	18.20%	Upgrade
Earnings Yield	-4.73%	-5.11%	-7.42%	-2.10%	-1.83%	-5.89%	Upgrade
FCF Yield	11.97%	12.93%	8.74%	5.60%	-5.42%	-85.75%	Upgrade
Buyback Yield / Dilution	0.11%	0.11%	-	-	-4.95%	-5.81%	Upgrade

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.